Shots.

• The company has submitted MAA to COFEPRIS (the health regulatory authority for Mexico) for its COVI-STIX rapid diagnostic test to detect SARS-CoV-2 virus nucleocapsid antigen in nasal samples of patients
• The test provides results in 15min. with positive detection as quickly as 2min for patient samples with high viral load.
• Additionally- Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses- including COVI-GUARD- COVI-AMG- COVI-SHIELD- Gene-MAb- COVI-MSC and COVI-DROPS and diagnostic test solutions- including COVI-TRACK- COVI-STIX and COVI-TRAC

 ­ Ref: Sorrento | Image: Sorrento